2011
DOI: 10.1021/bc2003555
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Biological Evaluation of Water-Soluble Progesterone-Conjugated Probes for Magnetic Resonance Imaging of Hormone Related Cancers

Abstract: Progesterone receptor (PR) is strongly associated with disease prognosis and therapeutic efficacy in hormone related diseases such as endometriosis and breast, ovarian, and uterine cancers. Receptor status is currently determined by immunohistochemistry assays. However, noninvasive PR imaging agents could improve disease detection and help elucidate pathological molecular pathways, leading to new therapies and animal disease models. A series of water-soluble PR-targeted magnetic resonance imaging (MRI) probes … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
36
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 36 publications
(37 citation statements)
references
References 43 publications
(132 reference statements)
1
36
0
Order By: Relevance
“…Cells were seeded in 96-well plates at 7.5 × 10 3 cells/well and incubated with drugs (10 μM) for 10 hours at 37°C in a 5% CO 2 incubator. Luciferase readout was measured as described previously(53). Secondary assay : MOE cells were treated with 10 μM of “hits”.…”
Section: Methodsmentioning
confidence: 99%
“…Cells were seeded in 96-well plates at 7.5 × 10 3 cells/well and incubated with drugs (10 μM) for 10 hours at 37°C in a 5% CO 2 incubator. Luciferase readout was measured as described previously(53). Secondary assay : MOE cells were treated with 10 μM of “hits”.…”
Section: Methodsmentioning
confidence: 99%
“…Eu-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) (Eu-DOTA) [34], Eu-(1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid) (Eu-DO3A) [35] and Tb-(1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid) (Tb-DO3A) [36] were prepared by following the literature procedures. All the solvents used were of analytical grade.…”
Section: Methodsmentioning
confidence: 99%
“…Plasmid containing progesterone responsive element (PRE) fused to firefly luciferase obtained from Dr. Ken Korach, (NIEHS, NIH, Research Triangle, NC) [17] was transfected into T47D cells (0.1 μg/well) and HSEC (0.5 μg/well) using Lipofectamine 2000 (Life Technologies, Inc. Carlsbad, CA) in Opti-MEM according to the manufacturer’s protocol (Life Technologies, Inc. Carlsbad, CA). PRE-luciferase transfection efficiencies were normalized to an independent control plasmid expressing beta-galactosidase (β-gal) or renilla luciferase (0.1 μg or 0.5 μg), a kind gift of Dr. William T. Beck, (University of Illinois, Chicago, IL), cotransfected simultaneously.…”
Section: Methodsmentioning
confidence: 99%